|
|
Article: Study Shows Actonel(R) Reduces Vertebral Fracture Risk 70 Percent in Patients on Chronic Steroid Therapy.
- Article from:
- PR Newswire
- Article date:
- October 24, 2001
CopyrightCOPYRIGHT 2001 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Bisphosphonates Recommended by American College of Rheumatology (ACR)
for Glucocorticoid-Induced Osteoporosis (GIO)
LAS VEGAS, Oct. 24 /PRNewswire/ --
Vertebral fracture risk in men and women who take oral glucocorticoid treatment (greater than or equal to 7.5 mg/day prednisone or equivalent) for chronic diseases is significantly reduced with Actonel(R) (risedronate sodium tablets) 5 mg in just one year, according to data presented today at the 66th Annual Scientific Meeting of the American College of Gastroenterology in Las Vegas.
(Logo: http://www.newscom.com/cgi-bin/prnh/20000501/NYM197 )
Patients on Actonel 5 mg daily ...